By Chloe Bakst and Rachael Peroutky The shortage of obesity drugs has created a pressing challenge within the healthcare industry, affecting patients, providers, pharmacies, and payers alike. Healthcare leaders must understand the implications of this extended shortage and take proactive steps to mitigate its impact. Here's our take on how an extended shortage could impact stakeholders, what healthcare leaders can do to respond, and how long the shortage will last.
